These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 14627761

  • 1. Sibutramine treatment in obesity: predictors of weight loss including rorschach personality data.
    Elfhag K, Rössner S, Carlsson AM, Barkeling B.
    Obes Res; 2003 Nov; 11(11):1391-9. PubMed ID: 14627761
    [Abstract] [Full Text] [Related]

  • 2. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
    Hainer V, Kunesova M, Bellisle F, Hill M, Braunerova R, Wagenknecht M.
    Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
    [Abstract] [Full Text] [Related]

  • 3. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K, Finer N, Rössner S.
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [Abstract] [Full Text] [Related]

  • 4. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [Abstract] [Full Text] [Related]

  • 5. Food intake with an antiobesity drug (sibutramine) versus placebo and rorschach data: a crossover within-subjects study.
    Elfhag K, Barkeling B, Carlsson AM, Lindgren T, Rossner S.
    J Pers Assess; 2004 Apr; 82(2):158-68. PubMed ID: 15041522
    [Abstract] [Full Text] [Related]

  • 6. Rorschach personality predictors of weight loss with behavior modification in obesity treatment.
    Elfhag K, Rossner S, Lindgren T, Andersson I, Carlsson AM.
    J Pers Assess; 2004 Dec; 83(3):293-305. PubMed ID: 15548466
    [Abstract] [Full Text] [Related]

  • 7. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [Abstract] [Full Text] [Related]

  • 8. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL, Apovian CM, Aronne LJ, Fernstrom MH, Frank A, Greenway FL, Heber D, Kushner RF, Cwik KM, Walch JK, Hewkin AC, Blakesley V.
    Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
    [Abstract] [Full Text] [Related]

  • 9. Sibutramine treatment in obesity: initial eating behaviour in relation to weight loss results and changes in mood.
    Elfhag K, Rössner S, Barkeling B, Rooth P.
    Pharmacol Res; 2005 Feb; 51(2):159-63. PubMed ID: 15629262
    [Abstract] [Full Text] [Related]

  • 10. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N, Ryan DH, Renz CL, Hewkin AC.
    Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525
    [Abstract] [Full Text] [Related]

  • 11. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
    Di Francesco V, Sacco T, Zamboni M, Bissoli L, Zoico E, Mazzali G, Minniti A, Salanitri T, Cancelli F, Bosello O.
    Ann Nutr Metab; 2007 Mar; 51(1):75-81. PubMed ID: 17356258
    [Abstract] [Full Text] [Related]

  • 12. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM, Balance Study Group.
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [Abstract] [Full Text] [Related]

  • 13. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio Paparatti U, Pasanisi F.
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [Abstract] [Full Text] [Related]

  • 14. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [Abstract] [Full Text] [Related]

  • 15. Psychological variables associated with weight loss in obese patients seeking treatment at medical centers.
    Dalle Grave R, Calugi S, Corica F, Di Domizio S, Marchesini G, QUOVADIS Study Group.
    J Am Diet Assoc; 2009 Dec; 109(12):2010-6. PubMed ID: 19942018
    [Abstract] [Full Text] [Related]

  • 16. Combined dietary and pharmacological weight management in obese hypopituitary patients.
    Mersebach H, Klose M, Svendsen OL, Astrup A, Feldt-Rasmussen U.
    Obes Res; 2004 Nov; 12(11):1835-43. PubMed ID: 15601980
    [Abstract] [Full Text] [Related]

  • 17. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder.
    Bauer C, Fischer A, Keller U.
    Diabetes Obes Metab; 2006 May; 8(3):289-95. PubMed ID: 16634988
    [Abstract] [Full Text] [Related]

  • 18. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 19. Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.
    Andersson C, Weeke P, Fosbøl EL, Brendorp B, Køber L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, Torp-Pedersen C, SCOUT Executive Steering Committee, SCOUT investigators.
    Metabolism; 2009 Aug; 58(8):1109-15. PubMed ID: 19454355
    [Abstract] [Full Text] [Related]

  • 20. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
    Hung YJ, Chen YC, Pei D, Kuo SW, Hsieh CH, Wu LY, He CT, Lee CH, Fan SC, Sheu WH.
    Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.